ELYSIUM THERAPEUTICS, INC.
Creating safer, more effective solutions for pain management and the opioid crisis
Akron, United States · Founded 2015
- Headquarters
- Akron, Ohio
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- elysiumrx.com
- Last Round
- SAFEJan 2026
- Rounds
- 2
Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.
About
Elysium Therapeutics is a pharmaceutical company developing abuse-deterrent and diversion-resistant opioid formulations using their proprietary molecular deactivation (XpiRx) technology. Their SMART product solutions, including O2P (Oral Overdose Protected hydrocodone) and SOOPR (a rescue agent for synthetic opioid overdose), have demonstrated human proof-of-concept. The company has received approximately $16M in NIH SBIR and non-dilutive grant funding.
Summary
ELYSIUM THERAPEUTICS, INC. is a Biotech company based in Akron, United States, founded in 2015. Its most recent funding was a SAFE round in Jan 2026. Investors include Mesa Verde Venture Partners and New York Angels.
Funding History
2026 (est.)
Sign up to see all 2 events
Funding: SAFE. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/elysium-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/elysium-therapeutics-inc" alt="ELYSIUM THERAPEUTICS, INC. on Indexed.vc" width="260" height="76" /></a>